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Summary
Objective: To evaluate the reproducibility of ambulatory blood pressure monitoring (ABPM) (SpaceLabs-90207) and 
placebo effect on ABPM.
Methods: Blood pressure was measured in the office and over two ABPM periods with an interval from one to ten months 
(mean 4.9 months), in 26 patients with type 2 diabetes mellitus and hypertension. Eleven patients (G1) had two ABPMs
without taking antihypertensive drugs for 15 days, whereas G2 (N=15) had the second ABPM after administration of a 
placebo for 15 days. 
Results: In the evaluation of the coefficient of variation (CV) of diurnal (awake) systolic BP (DSBP), of diurnal (awake) 
diastolic BP (DDBP), of 24-hour systolic BP (24hSBP) and of 24-hour diastolic BP (24hDBP), the values found were 4.6%, 
3.9%, 5.0%, 4.0% for G1 and 4.3%, 5.1%, 3.7%, 5.1% for G2 respectively. We also determined the CV of nocturnal (sleep) 
systolic and diastolic BP (NSBP and NDBP) for G1 (7.7%; 8.2%) and G2 (5.6%; 6.3%). Heart rate CV during alertness and 
sleep were: G1=5.9% and 9.0%; G2=6.9% and 5.8% respectively. When the total number of ´patients was analyzed, all 
variables showed a strong correlation between the first and second ABPM measurements (DSBP, r = 0.76; P < 0.001; 
DDBP, r = 0.65; p < 0.001; 24hSBP, r = 0.77; p < 0.001; 24hDBP, r = 0.70; p < 0.001; NSBP, r = 0.62; p < 0.001; 
NDBP, r = 0.52; p < 0.01). Office systolic and diastolic BP and 24hSBP and 24hDBP also showed correlation (r = 0.65; 
p < 0.001; r = 0.57; p < 0.01).
Conclusion: Mean of pressure levels measured by ABPM presented good reproducibility and were not affected by 
placebo.
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Introduction
Arterial hypertension occurs twice as frequently in patients 
with diabetes mellitus (DM) as compared with normal 
individuals 1,2. Macro and microvascular complications of 
DM are also accelerated by the presence of hypertension 
3,4. Therefore, it has been recommended that patients with 
hypertension and diabetes be diagnosed and treated early 
5. However, because blood pressure (BP) is a very variable 
parameter, the standard technique to establish the diagnosis 
of hypertension remains controversial 6.
In recent years, ambulatory blood pressure monitoring 
(ABPM) has been introduced in the study of hypertension 
and has become an important tool to inform clinical decision 
making 7. Several pieces of data 8-10 have suggested that mean 
24-hour BP presents a better correlation with lesions of target 
organs than isolated office BP measurements. It has also been 
demonstrated that ABPM presents higher reproducibility as 
compared with office BP for hypertensive 11,12 and diabetic 
hypertensive 13 individuals alike. At present ABPM can be 
particularly instrumental in detecting autonomic dysfunction 
and nocturnal blood pressure load increase in hypertensive 
diabetic individuals 14. Absence of or reduced BP descent 
during sleep (nondipping) have been associated with a higher 
risk of cardiovascular complications 15,16.
Additionally, great differences between measurements 
taken on two consecutive days  have been reported in studies 
focusing on the reproducibility of the 24hBP mean 17 and on 
BP descent during sleep 18 measured by ABPM, especially as 
a result of the variety of devices available in the market, many 
of which have not yet been tested enough. The ascertainment 
of the coefficient of variation of ABPM devices will make their 
results more reliable.
Therefore, this study was designed to assess the 
reproducibility of ABPM measurements and the placebo 
effect on ABPM to determine its degree of reliability as to the 
measurement of pressure levels in patients with type 2 DM 
and hypertension.
Methods
Patients - Twenty-six patients with type 2 DM and arterial 
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determine diastolic DS. Individuals who presented BP descent 
during sleep greater than or equal to ten percent (10%) 
(dippers) as compared with alertness BP were considered 
normal, whereas individuals who presented descent below 
these levels were called “nondippers”.
Statistical analysis - All the data were presented as mean 
± standard deviation or median with interval of variation. For 
the analysis of correlation, Pearson’s or Spearman’s correlation 
coefficients were calculated between variables considering 
the type of distribution -  normal or non-normal -  in the 
population. The coefficients of variation (CV) for all pressure 
measurements and for the heart rate of the first and second 
ABPM were also calculated. The CV consisted of standard 
deviation of the mean of differences divided by the absolute 
mean of the two samples  multiplied by 100. P < 0.05 was 
considered significant. All the analyses were carried out 
using the Sigmastat program (1992-1994 - Jandel Scientific 
Corporation- USA).
Results
The age and BMI of the two groups were: G1=59 ± 8 years 
and 31 ± 5 kg/m2 and G2=56 ± 8 years and 27 ± 4 kg/m2,
respectively. Table 1 shows pressure measurements assessed 
by ABPM for each group. There was no statistically significant 
difference between all the measurements assessed by ABPM 
between the two groups, and within each group when the 
first and second ABPM values were compared (Table 1). With 
respect to the stage of hypertension of G1 patients, three (27%) 
were stage I patients, six (55%) were stage II patients and two 
(18%) were stage III patients. As for G2 patients, two (13.5%) 
were in stage I, six (40%) were in stage II and seven (46.5%) 
were in stage III. Mean systolic and diastolic BP and heart 
rate (HR) measured in the office were 173±20, 98±7 and 
73±11, respectively for G1 and 166±20, 97±9 and 77±9, 
respectively for G2.
When we assessed the CV of alertness systolic BP (DSBP), 
alertness diastolic BP (DDBP), 24-hour systolic BP (24hSBP) 
and 24-hour diastolic BP (24hDBP), we found the following 
hypertension attended at  our Hypertension Clinic during a 
year were assessed and submitted to ABPM at two different 
times with an interval that varied from one to ten months 
(mean of 4.9 months). All the patients were submitted to the 
first ABPM without taking anti-hypertensive medication for 
fifteen days. The patients were then divided into two groups: 
group 1 (G1) (N = 11) underwent the same procedure for the 
second ABPM, whereas group 2 (G2) (N = 15) underwent 
the second ABPM after using a placebo during fifteen days. 
Office blood pressure was determined for each patient when 
the ABPM device was attached. Inclusion criteria were the 
following: all patients should be between 30 and 75 years 
of age, with body mass index (BMI) lower than or equal to 
40 kg/m2, type 2 DM treated only with diet or oral glucose-
lowering drugs (with no use of insulin), arterial hypertension, 
normal levels of serum creatinine and 24-hour proteinuria 
(<150 mg/24h) and no previous history of myocardial 
infarction, angina and cerebrovascular accident. Individuals 
that didn’t meet the criteria above were excluded from the 
study. Patients were later classified according to the stage 
of hypertension (19) based on the mean of three office BP 
measurements taken with the patient in a sitting position, with 
a one-minute interval between measurements, on the day of 
the first ABPM period.
Arterial hypertension was defined, on office assessment, 
DV V\VWROLF DQGGLDVWROLF  %3PP+J LQ UHSHDWHG
measurements 20. The diagnosis of DM was based on standard 
criteria 21. Patients with type 2 DM were those with disease 
onset after 30 years of age, with no need for insulin since the 
time of diagnosis. All patients were previously informed of 
all the procedures they would be submitted to, and agreed 
to participate in the study. The assessment protocol was 
approved by the Ethics Committee of the Federal University 
of São Paulo.
Arterial Pressure Ambulatory Monitoring - ABPM was 
carried out using the oscillometric method with a portable 
SpaceLabs - 90207 device (Spacelabs, Inc. Redmond, WA-
USA). Patients were submitted to ABPM after the interruption 
of anti-hypertensive medication for fifteen days or after using 
placebo for the same period. The monitor was attached in the 
morning and removed after 24 hours. The individuals were 
told to maintain their ordinary activities and present a report 
with the time of each activity. The device was programmed 
to perform four measurements per hour, and the systolic and 
diastolic pressure means were ascertained during each hour, 
during alertness, sleep time and over the 24 hour period. 
The alertness period included activities from 8 a.m. to 8 
p.m., whereas the period between 8 p.m. to 8 a.m. was 
considered sleep time. Systolic BP measurements above 260 
mmHg and below 70 mmHg, and diastolic BP measurements 
above 150 mmHg and below 40 mmHg were automatically 
excluded from the analysis. The limit for heart rate detection 
was between 200 and 20 bpm. The test was accepted if at 
least 75% of the measurements taken throughout the 24-
hour period had been performed successfully. Additionally, 
the calculation of BP descent during sleep (DS) was carried 
out using the following formula: systolic DS (%) = (systolic 
BP during alertness – systolic BP during sleep) x 100 / systolic 
BP during alertness. The same calculation was carried out to 
G1 (n=11) G2 (n=15)
1º ABPM 2º ABPM 1º ABPM 2º ABPM
DSBP 146±14 145±14 150±14 148±20
NSBP 135±17 135±19 136±12 137±19
DDBP 91±11 89±8 92±7 90±10
NDBP 79±11 80±12 78±7 79±9
HRD 80±7 83±9 79±12 81±10
HRS 71±10 73±10 68±9 69±10
* There was no statistically significant difference regarding all the 
measurements assessed by ABPM between the two groups and within 
each group when the first and second ABPM values.
DSBP=Systolic BP during alertness; NSBP=Systolic BP during sleep; 
DDBP=Diastolic BP during alertness; NDBP=Diastolic BP during sleep; 
HRD=HR during alertness; HRS=HR during sleep.
Table 1 - Pressure measurements assessed by ABPM
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values: 4.6%, 3.9%, 5.0% and 4.0% for G1 and 4.3%, 5.1%, 
3.7% and 5.1% for G2, respectively (figure 1). We also 
determined CV for systolic and diastolic BP during sleep (NSBP 
and NDBP) for G1 (7.7% and 8.2%) and G2 (5.6% and 6.3%). 
The coefficients of variation for alertness and sleep heart rate 
were: G1=5.9% and 9.0%; G2=6.9% and 5.8%, respectively. 
Analyzing the total number of patients (N=26), all the variables 
showed strong correlations between the first and second ABPM 
values (DSBP, r = 0.76; P<0.001; DDBP, r = 0.65; p<0.001; 
24-hour systolic BP, r = 0.77; p<0.001; 24-hour diastolic BP, 
r = 0.70; p<0.001; NSBP, r = 0.62; p<0.001; NDBP, r = 
0.52; p<0.01). There were also correlations between office 
systolic and diastolic BP and 24-hour systolic and diastolic BP 
(r = 0.65; p<0.001; r = 0.57; p<0.01), respectively. When 
we compared systolic and diastolic DS values for the first and 
second ABPM values for G1 and G2, we found no significant 
difference (8.8 %(-2.0 to 14.3) as compared with 5.6 %(-1.7 
to 20.7), NS; and 13.7 % (5.5 to 18.7) as compared with 9.0 
% (-1 to 30.9), NS for G1 and 8.9 % (-1.2 to 17) as compared 
with 6.1 % (0 to 19.7), NS; and 14.4 % (2.2 to 31.1) as 
compared with 13.2% (4.5 to 19.4), NS for G2, respectively). 
Finally, analyzing both groups jointly, and considering a cut-
off value of 10% for nocturnal descent to separate dippers 
from nondippers, we found that 42% of both diabetic and 
hypertensive patients changed category for systolic DS and 
46% changed category for diastolic DS upon repetition of 
the monitoring after an interval of one to ten months. As 
for G1, three (27%) out of eleven patients changed category 
for systolic DS and six (54%) out of eleven patients changed 
category for diastolic DS. For G2, eight (53%) out of fifteen 
patients changed category for systolic DS and six (40%) out of 
fifteen patients changed category for diastolic DS. When we 
compared the percentage of patients that changed category 
within each group, we found no significant difference.
Discussion
The results of our study showed that mean pressure values 
assessed by ambulatory blood pressure monitoring presented 
good reproducibility and were not affected by placebo. These 
findings are similar to few data found in the literature 13,22.
We have previously described (unpublished data) that 
sleeptime systolic BP in diabetic hypertensive patients related 
to a high prevalence of left ventricular hypertension. However, 
when we used BP nocturnal decent, this effect was not 
observed. This was probably due to the low reproducibility 
of BP descent during sleep in these patients. This study 
supports this hypothesis, as it found that 42% of hypertensive 
individuals with DM changed category (dipping/non-dipping) 
in a second measurement carried out after an interval of one 
to ten months. Verdecchia et al 23 documented that 73% of 
the hypertensive patients remained in the same category 
(dipping/non-dipping) after a second ABPM with a 3 to 5-
day interval, whereas 27% changed from one group to the 
other. According to data from Stenehjem et al 24, 82% of the 
patients had their nocturnal pattern (non-dipping) changed 
to dipping after repeated measurements. This slightly better 
reproducibility of nocturnal descent in hypertensive subjects as 
compared with our subjects with DM and hypertension could 
be partly justified by other factors that influence nocturnal 
descent in diabetic subjects, including poor glucose level 
management 25 and diabetic autonomic neuropathy 26,27. A s 
concerns circadian BP variations in type I diabetic patients, 
persistent abnormal variability seems to occur early and 
frequently among those with increased urinary excretion of 
albumin. Loss of nocturnal descent (nondippers) assessed 
in two ABPM periods was observed in 80, 58, 18 and 10% 
of diabetic patients with proteinuria, microalbuminuria, 
normoalbuminuria and control group respectively 28, which 
shows that the frequency of this abnormality increases as 
incipient nephropathy progresses 28-30. In our study, however, 
all the patients had normal levels of creatinin and proteinuria 
in the 24-hour period. Therefore, diabetic nephropathy could 
not account for the high variability in BP nocturnal descent in 
our group. 
We do not know of any data on the literature regarding the 
assessment of reproducibility with serial ABPM measurements, 
followed by ABPM performed after withdrawal of anti-
hypertensive medication and with the administration of 
placebo in hypertensive individuals with type 2 diabetes. 
Asmar et al 31 observed that, in hypertensive patients, the mean 
24-hour BP measured by ABPM was not affected by placebo. 
In patients with mild to moderate hypertension, Zakopoulos 
et al 32 demonstrated that systolic and diastolic BP values 
measured every hour, heart rate and BP descent during sleep 
were reproducible in four ABPMs carried out over a four-
month period. Additionally, Korner et al 33, in a study with 
children with type I diabetes concluded that BP values assessed 
by ABPM were reproducible, despite  markers of individual 
characteristics. Davis et al 34, however, demonstrated that the 
ABPM device itself disturbed sleep, and caused changes to the 
BP it was supposed to measure. Other causes for BP variability 
over the 24-hour period included methodological problems 
with ABPM during the night due to a different hydrostatic 
variability between the device’s cuff and the heart, level of 
activity during daytime and decreased accuracy of devices 
when measuring very high BP levels 17,18,35. Davis et al 34
overestimated systolic BP at 10 mmHg (ABP, Oxford Medical) 
Fig. 1 - Coefficients of variation of pressure measurements determined 
by ABPM. DSBP=Systolic BP during alertness; DDBP=Diastolic BP during 
alertness; NSBP=Systolic BP during sleep; NDBP=Diastolic BP during sleep; 
24hSBP=24-hour systolic BP; 24hDBP=24-hour diastolic BP.
Group 1 (without medication)
Group 2 (placebo)
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and at 6mmHg (TM 2420, A&D), whereas diastolic BP was 
not affected. This disorder might lead to underestimation 
of pressure descent during sleep. Other devices (SpaceLabs 
and Sandoz Pressure System), however, did not present this 
problem in a study with concurrent assessment of intraarterial 
pressure 36.
Therefore, our study suggests that ABPM (Spacelabs-
90207, Inc. Redmond, WA - USA) is a reliable tool to monitor 
BP variations and confirms its trustworthiness for use in 
hypertensive patients with type 2 diabetes mellitus.
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